GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (NAS:EVO) » Definitions » Shiller PE Ratio

Evotec SE (Evotec SE) Shiller PE Ratio : 64.00 (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Evotec SE Shiller PE Ratio?

As of today (2024-05-21), Evotec SE's current share price is $5.12. Evotec SE's E10 for the quarter that ended in Dec. 2023 was $0.08. Evotec SE's Shiller PE Ratio for today is 64.00.

The historical rank and industry rank for Evotec SE's Shiller PE Ratio or its related term are showing as below:

EVO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 63.75   Med: 155.52   Max: 592.25
Current: 64

During the past years, Evotec SE's highest Shiller PE Ratio was 592.25. The lowest was 63.75. And the median was 155.52.

EVO's Shiller PE Ratio is ranked worse than
88.01% of 534 companies
in the Drug Manufacturers industry
Industry Median: 24.875 vs EVO: 64.00

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evotec SE's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.049. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.08 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Evotec SE Shiller PE Ratio Historical Data

The historical data trend for Evotec SE's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Shiller PE Ratio Chart

Evotec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 191.86 - 167.00 90.59 153.25

Evotec SE Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.36 90.59 122.56 127.41 153.25

Competitive Comparison of Evotec SE's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evotec SE's Shiller PE Ratio falls into.



Evotec SE Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Evotec SE's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5.12/0.08
=64.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Evotec SE's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.049/123.7729*123.7729
=-0.049

Current CPI (Dec. 2023) = 123.7729.

Evotec SE Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 -0.116 99.356 -0.145
201403 -0.021 99.543 -0.026
201406 -0.002 99.543 -0.002
201409 -0.019 99.823 -0.024
201412 0.006 99.543 0.007
201503 -0.005 99.717 -0.006
201506 0.062 100.417 0.076
201509 -0.011 100.417 -0.014
201512 0.022 99.717 0.027
201603 -0.006 100.017 -0.007
201606 0.017 100.717 0.021
201609 0.039 101.017 0.048
201612 0.058 101.217 0.071
201703 0.027 101.417 0.033
201706 0.011 102.117 0.013
201709 0.012 102.717 0.014
201712 0.041 102.617 0.049
201803 0.012 102.917 0.014
201806 0.058 104.017 0.069
201809 0.134 104.718 0.158
201812 0.119 104.217 0.141
201903 0.051 104.217 0.061
201906 -0.011 105.718 -0.013
201909 0.072 106.018 0.084
201912 0.028 105.818 0.033
202003 0.061 105.718 0.071
202006 -0.039 106.618 -0.045
202009 -0.006 105.818 -0.007
202012 0.000 105.518 0.000
202103 0.190 107.518 0.219
202106 0.223 108.486 0.254
202109 0.482 109.435 0.545
202112 -0.113 110.384 -0.127
202203 -0.226 113.968 -0.245
202206 -0.085 115.760 -0.091
202209 -0.134 118.818 -0.140
202212 -0.079 119.345 -0.082
202306 -0.043 123.140 -0.043
202309 -0.117 124.195 -0.117
202312 -0.049 123.773 -0.049

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Evotec SE  (NAS:EVO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Evotec SE Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Evotec SE's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE (Evotec SE) Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.